Hemodynamic Assessment of the Right Ventricle Using Pressure-volume Loop Catheter and Pulmonary Artery Catheter in Patients Undergoing Left Ventricular Assist Device Placement

Sponsor
University of Minnesota (Other)
Overall Status
Recruiting
CT.gov ID
NCT04478890
Collaborator
(none)
5
1
19.9
0.3

Study Details

Study Description

Brief Summary

This study will include the placement of a pressure volume (PV) loop catheter in the right atrium of patients undergoing left ventricular assist device (LVAD) placement and measure relevant PV loop data. Transesophageal echocardiography (TEE) and pulmonary artery (PA) catheter parameters as comparators to the PV loop will be recorded.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Hemodynamic assessment

Detailed Description

This will be a prospective observational study design to characterize right ventricular function in 5 consecutive patients undergoing LVAD implantation at the University of Minnesota Medical Center (UMMC). Pre-, intra- and postoperative care delivery to all enrolled and consented patients will meet the standards of care otherwise delivered to patients undergoing LVAD implantation at UMMC; care delivery will be at the discretion of the clinical care team and will not be altered based on the output of the right ventricular high-fidelity conductance catheters.

Study Design

Study Type:
Observational
Anticipated Enrollment :
5 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Hemodynamic Assessment of the Right Ventricle Using Pressure-volume Loop Catheter and Pulmonary Artery Catheter in Patients Undergoing Left Ventricular Assist Device Placement at the University of Minnesota Medical Center
Actual Study Start Date :
Aug 1, 2021
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Observational Group

Characterize right ventricular function while undergoing LVAD implantation

Diagnostic Test: Hemodynamic assessment
Hemodynamic assessment of the right ventricle using pressure-volume loop catheter and pulmonary artery catheter

Outcome Measures

Primary Outcome Measures

  1. Stroke volume [Approximately 4-6 hours]

    Stroke volume will be reported in units of millilitres per square metre

  2. Heart rate [Approximately 4-6 hours]

    Heart rate will be reported in units of beats per minute

  3. Ejection fraction [Approximately 4-6 hours]

    Ejection fraction will be reported as a percent

  4. Cardiac output [Approximately 4-6 hours]

    Cardiac output will be reported in units of milliliters per minute

  5. End-systolic pressure [Approximately 4-6 hours]

    End-systolic pressure will be reported in units of mmHG

  6. End-systolic volume [Approximately 4-6 hours]

    End-systolic volume will be reported in units of milliliters

  7. End-diastolic pressure [Approximately 4-6 hours]

    End-diastolic pressure will be reported in units of mmHG

  8. End-diastolic volume [Approximately 4-6 hours]

    End-diastolic volume will be reported in units of milliliters

  9. Right ventricular dP/dt [Approximately 4-6 hours]

    Right ventricular dP/dt will be reported in units of mmHg per second

  10. Stroke work [Approximately 4-6 hours]

    Stroke work will be reported in units of gram meters (g*m)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing left ventricular assist device (LVAD) placement at the University of Minnesota Medical Center
Exclusion Criteria:
  • Patients with a history of internal jugular vein thrombosis or known reasons for not being able to thread a central venous catheter through either internal jugular vein

  • Patients with a history of known esophageal strictures, esophageal or stomach cancer, esophageal varices, or any patient in whom a TEE is contraindicated

  • Patients with permanent pacemakers whose right ventricle is being paced and not in normal sinus rhythm

  • Patients unable to consent to participating in the study

  • Patients who are pregnant will be excluded, as part of standard care, all female patients are screened for pregnancy prior to surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Minnesota Minneapolis Minnesota United States 55455

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: Tjorvi Perry, MD, MMSc, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT04478890
Other Study ID Numbers:
  • ANES-2020-28725
First Posted:
Jul 21, 2020
Last Update Posted:
May 4, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 4, 2022